Technical Analysis for KALA - Kala Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
4.55 | 0.66% | 0.03 |
KALA closed up 0.66 percent on Thursday, September 19, 2019, on 62 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Sep 27
*** please verify all earnings dates ***| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| See historical KALA trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Weak + Overbought | Other | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Weak, Overbought and Reversal Signs | Reversal | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Up 4 Days in a Row | Strength | 0.00% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/27/2019
- Sector: Healthcare
- Industry: Biotechnology
Kala Pharmaceuticals Inc. is a United States-based company that is developing ophthalmic treatments based on the Company’s Mucosal Penetrating Product (MPP) platform. The Company’s topical ocular MPP formulations enhance penetration of diverse therapeutic agents into ocular tissue, including those in the back of the eye, by facilitating penetration through the mucus layer of tear film. Its product development pipeline includes a 1% formulation of loteprednol etabonate to treat post-surgical ocular inflammation and pain; a 0.25% LE-MPP formulation for dry eye, blepharitis, and retinal disease, and a topically applied receptor tyrosine kinase inhibitir (RTKi-MPP) for the treatment of wet age-related macular degeneration (AMD).
Medicine Medical Specialties Pain Organ Systems Macular Degeneration Wet Age Related Macular Degeneration Glucocorticoids Retinal Disease Post Surgical Ocular Inflammation
Medicine Medical Specialties Pain Organ Systems Macular Degeneration Wet Age Related Macular Degeneration Glucocorticoids Retinal Disease Post Surgical Ocular Inflammation
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more KALA news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 11.09 |
| 52 Week Low | 3.5 |
| Average Volume | 328,287 |
| 200-Day Moving Average | 6.1668 |
| 50-Day Moving Average | 4.7606 |
| 20-Day Moving Average | 4.046 |
| 10-Day Moving Average | 4.218 |
| Average True Range | 0.2729 |
| ADX | 27.51 |
| +DI | 22.5787 |
| -DI | 16.4423 |
| Chandelier Exit (Long, 3 ATRs ) | 3.8612 |
| Chandelier Exit (Short, 3 ATRs ) | 4.3187 |
| Upper Bollinger Band | 4.5655 |
| Lower Bollinger Band | 3.5265 |
| Percent B (%b) | 0.99 |
| BandWidth | 25.679684 |
| MACD Line | -0.0508 |
| MACD Signal Line | -0.1792 |
| MACD Histogram | 0.1284 |
| Fundamentals | Value |
|---|---|
| Market Cap | 110.23 Million |
| Num Shares | 24.2 Million |
| EPS | -32.85 |
| Price-to-Earnings (P/E) Ratio | -0.14 |
| Price-to-Sales | 0.00 |
| Price-to-Book | 0.00 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.73 | ||||
| Resistance 3 (R3) | 4.73 | 4.68 | 4.70 | ||
| Resistance 2 (R2) | 4.68 | 4.63 | 4.68 | 4.69 | |
| Resistance 1 (R1) | 4.61 | 4.60 | 4.59 | 4.61 | 4.68 |
| Pivot Point | 4.56 | 4.56 | 4.54 | 4.56 | 4.56 |
| Support 1 (S1) | 4.49 | 4.51 | 4.47 | 4.49 | 4.42 |
| Support 2 (S2) | 4.44 | 4.48 | 4.44 | 4.41 | |
| Support 3 (S3) | 4.37 | 4.44 | 4.40 | ||
| Support 4 (S4) | 4.37 |
